Skip to main content

Selecting medical research data platforms for translational biomedical research: a five-tier overview and requirement-weighted assessment framework.

Frontiers in digital health

Authors: Marc Jacobs, Samad Goudarzi, Jan Stücke, Robin Röhm, Timo Kanninen, Tero Oinonen, Petra Ritter, Michael Schirner, Fabian Prasser, Arman Bhagwagar, Bernd Matzenbach, Hartmut Schultze, Joachim Schultze, Mathias Göschl, Henrik Matthies, Kenneth R Evans, Moyez Dharsee, Christian Stephan, Marvin Belz, Philip Gribbon, Katja Herzog, Chester Chen, David Ruau, Ittai Dayan, Adrish Sannyasi, Dieter Kranzlmüller, Naweiluo Zhou, Jens Warfsmann, Martin Hoffmann, Rudi Schmidt, Martin Hofmann-Apitius

INTRODUCTION: Translational biomedical research is increasingly collaborative and multimodal, making secure, high-quality data capture, curation, and analytics a major challenge. This work aims to provide an overview of existing medical research data platforms to support informed platform selection for translational biomedical research.

METHODS: As part of an ongoing Fraunhofer Request for Proposal (RFP) process, we developed a requirements assessment tool for users across the Fraunhofer ecosystem. In parallel, we compiled a structured overview of medical research data platforms through an open collaboration between academic and industry experts, who supplemented our market screening by identifying additional relevant platforms. Using a standardized questionnaire on key aspects of distributed data collaboration, we collected harmonized platform descriptions and organized them into a side-by-side overview with an accompanying feature weighting matrix.

RESULTS: The study yielded a structured, comparative characterization of medical research data platforms across five functional classes, highlighting common strengths in security, interoperability, data quality, and multimodal data support. We devised (developed) a platform feature-partner weight matrix that enables context-sensitive platform scoring without imposing a predefined global ranking. In this way, users can align platform scoring with their specific translational research requirements.

DISCUSSION: This structured, overview is intended to accelerate decision-making in the medical research community when choosing data platforms. By supporting context-sensitive, feature-weighted selection rather than one-size-fits-all comparisons, it acknowledges diversified research needs and can be updated as technologies and practices evolve.

© 2026 Jacobs, Goudarzi, Stücke, Röhm, Kanninen, Oinonen, Ritter, Schirner, Prasser, Bhagwagar, Matzenbach, Schultze, Schultze, Göschl, Matthies, Evans, Dharsee, Stephan, Belz, Gribbon, Herzog, Chen, Ruau, Dayan, Sannyasi, Kranzlmüller, Zhou, Warfsmann, Hoffmann, Schmidt and Hofmann-Apitius.

PMID: 42388293

Participating cluster members